Answers are grounded in this paper and cite their sources.
Advances in digital health technologies have the potential to redesign chronic disease management and enable new directions for better patient outcomes and improved healthcare delivery. The focus here is on congestive heart failure, diabetes mellitus, and opioid use disorder, with an emphasis on the identification of barriers to equitable implementation and to propose research directions to enhance digital health efficacy and scalability. Investing in digital health solutions and innovation makes it possible for the healthcare industry to maintain quality of care, achieve better patient outcomes, and lower the burden of chronic diseases on a healthcare system. This paper explores common challenges and opportunities and proposes future research directions. Unlike earlier reports that focused on implementation barriers and provided an umbrella review of patient experiences, this article uniquely synthesizes evidence across conditions to establish best practices and cross-cutting barriers. In addition, it highlights the growing role of artificial intelligence in digital health—a topic often underexplored in prior works.
No takes yet. Share an insight, caveat, or question.
Muhammad Asif (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: